OncoCyte Corporation (NYSEMKT:OCX) will be announcing its earnings results after the market closes on Monday, August 14th. Analysts expect the company to announce earnings of ($0.12) per share for the quarter.

Shares of OncoCyte Corporation (OCX) opened at 4.50 on Monday. The stock’s market cap is $132.16 million. The firm has a 50 day moving average of $4.85 and a 200 day moving average of $5.48. OncoCyte Corporation has a one year low of $3.40 and a one year high of $7.95.

ILLEGAL ACTIVITY WARNING: “OncoCyte Corporation (OCX) to Release Quarterly Earnings on Monday” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://www.americanbankingnews.com/2017/08/07/oncocyte-corporation-ocx-to-release-quarterly-earnings-on-monday.html.

About OncoCyte Corporation

OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment.

Receive News & Ratings for OncoCyte Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoCyte Corporation and related companies with MarketBeat.com's FREE daily email newsletter.